slotkoers
Korea S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
37.600
KRW
|
+0,53%
|
|
+4,16%
|
-17,36%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
484.431
|
399.999
|
972.028
|
1.606.895
|
708.035
|
683.530
|
Bedrijfswaarde
1 |
456.144
|
393.699
|
967.039
|
1.656.756
|
735.710
|
762.403
|
K/w-verhouding
|
483
x
|
-176
x
|
234
x
|
36,5
x
|
29,1
x
|
-3.792
x
|
Dividendrendement
|
0,08%
|
0,07%
|
0,11%
|
-
|
0,74%
|
0,22%
|
Marktkapitalisatie/omzet
|
9,57
x
|
6,91
x
|
11,4
x
|
9,55
x
|
3
x
|
3,64
x
|
Bedrijfswaarde/omzet
|
9,01
x
|
6,8
x
|
11,3
x
|
9,84
x
|
3,12
x
|
4,07
x
|
Bedrijfswaarde/EBITDA
|
352
x
|
453
x
|
91,7
x
|
37,8
x
|
12,7
x
|
38,7
x
|
Bedrijfswaarde/FCF
|
-
|
-164.619.823
x
|
487.429.128
x
|
-150.333.076
x
|
14.997.349
x
|
-31.306.948
x
|
FCF Yield
|
-
|
-0%
|
0%
|
-0%
|
0%
|
-0%
|
Price to Book
|
10,2
x
|
9,08
x
|
20,6
x
|
2,99
x
|
1,31
x
|
1,28
x
|
Aantal aandelen (in duizenden)
|
10.554
|
10.554
|
10.554
|
15.800
|
15.017
|
15.023
|
Referentieprijs
2 |
45.900
|
37.900
|
92.100
|
101.700
|
47.150
|
45.500
|
Datum van publicatie
|
16/03/20
|
16/03/20
|
16/03/21
|
18/03/22
|
20/03/23
|
19/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
50.620
|
57.895
|
85.562
|
168.310
|
236.120
|
187.544
|
EBITDA
1 |
1.296
|
868,5
|
10.545
|
43.802
|
57.897
|
19.719
|
Bedrijfsresultaat (EBIT)
1 |
327,8
|
-3.245
|
6.364
|
36.407
|
44.274
|
4.079
|
Operationele Marge
|
0,65%
|
-5,6%
|
7,44%
|
21,63%
|
18,75%
|
2,18%
|
Resultaat voor belastingen (EBT)
1 |
859,2
|
-3.374
|
5.383
|
39.533
|
36.508
|
-7.464
|
Nettowinst (verlies)
1 |
1.002
|
-2.276
|
4.160
|
31.422
|
24.991
|
-174
|
Nettomarge
|
1,98%
|
-3,93%
|
4,86%
|
18,67%
|
10,58%
|
-0,09%
|
WPA
2 |
94,95
|
-215,6
|
394,2
|
2.784
|
1.622
|
-12,00
|
Free Cash Flow
|
-
|
-2.392
|
1.984
|
-11.021
|
49.056
|
-24.353
|
FCF-marge
|
-
|
-4,13%
|
2,32%
|
-6,55%
|
20,78%
|
-12,98%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
18,81%
|
-
|
84,73%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
47,69%
|
-
|
196,3%
|
-
|
Dividend per aandeel
2 |
35,00
|
25,00
|
100,0
|
-
|
350,0
|
100,0
|
Datum van publicatie
|
16/03/20
|
16/03/20
|
16/03/21
|
18/03/22
|
20/03/23
|
19/03/24
|
Fiscaal tijdperk: december |
2023 Q3
|
---|
Omzet
|
-
|
EBITDA
|
-
|
Bedrijfsresultaat (EBIT)
|
-
|
Operationele Marge
|
-
|
Resultaat voor belastingen (EBT)
|
-
|
Nettowinst (verlies)
|
-
|
Nettomarge
|
-
|
WPA
1 |
196,0
|
Dividend per aandeel
|
-
|
Datum van publicatie
|
14/11/23
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
49.861
|
27.675
|
78.872
|
Nettokaspositie
1 |
28.287
|
6.300
|
4.989
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
1,138
x
|
0,478
x
|
4
x
|
Free Cash Flow
|
-
|
-2.392
|
1.984
|
-11.021
|
49.056
|
-24.353
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-4,67%
|
8,21%
|
10,6%
|
4,85%
|
0,01%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-3,24%
|
5,51%
|
6,3%
|
4,19%
|
0,38%
|
Totale activa
1 |
-
|
70.330
|
75.527
|
498.472
|
597.024
|
-45.792
|
Nettoactief per aandeel
2 |
4.522
|
4.174
|
4.469
|
34.029
|
35.857
|
35.548
|
Cashflow per aandeel
2 |
2.206
|
1.288
|
864,0
|
1.199
|
3.155
|
836,0
|
Capex
1 |
4.780
|
5.344
|
4.788
|
10.876
|
6.915
|
11.397
|
Capex/omzet
|
9,44%
|
9,23%
|
5,6%
|
6,46%
|
2,93%
|
6,08%
|
Datum van publicatie
|
16/03/20
|
16/03/20
|
16/03/21
|
18/03/22
|
20/03/23
|
19/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -17,36% | 410 mln. | | -17,89% | 8,25 mld. | | +39,20% | 3,57 mld. | | -39,11% | 2,46 mld. | | -8,06% | 2,46 mld. | | -7,35% | 2,38 mld. | | -12,61% | 1,81 mld. | | -19,01% | 1,55 mld. | | -40,66% | 1,21 mld. | | +7,56% | 1,11 mld. |
Medische en diagnostische laboratoria
|